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Abstract
Oxidative stress results in activation of several signal transduction pathways controlled by
the PERK-substrate NRF2 (nuclear factor erythroid 2-related factor 2); meanwhile the ongo-
ing cell division cycle has to be blocked. It has been recently shown that Cyclin D1 got imme-
diately down-regulated via PERK pathway in response to oxidative stress leading to cell
cycle arrest. However, the effect of NRF2 on cell cycle regulation has not been explored yet.
We aimed to reveal a crosstalk between PERK-substrate NRF2 and the key elements of cell
cycle regulatory network upon oxidative stress using molecular biological techniques-
Although Cyclin D1 level remained constant, its activity was blocked by various stoichiomet-
ric inhibitors (such as p15, p21 and p27) even at low level of oxidative stress. The activity of
these CDK inhibitors completely disappeared, when the addition of oxidative agent was
combined with silencing of either PERK or NRF2.This further confirms the important role of
NRF2 in blocking Cyclin D1 with stoichiometric inhibitors at early stage of oxidative stress.
Introduction
From internal metabolism and external toxicant exposure several harmful reactive oxidants
(such as reactive oxygen (ROS) and nitrogen (RNS) species) might be formed generating oxi-
dative stress in the cell. A significant decrease in the antioxidant (e.g. glutathione) controlled
cellular defence mechanism can also lead to oxidative stress [1]. The highly reactive ROS and
RNS molecules can be generated even at physiological conditions formed in a well-controlled
manner, and they are also used by the immune system as a way to remove pathogens [2]. In
humans, however hyper-production of these reactive oxidants might have fatal consequences
by inducing serious diseases [3, 4]. Oxidative stress-generated effects are involved in neurode-
generative diseases (e.g. Parkinson’s disease), sickle-cell disease, toxicity of xenobiotics, heart
failure and cancer development [3, 4]. Therefore oxidative stress response mechanisms have to
be highly controlled [2].
The nuclear factor erythroid 2-related factor 2 (NRF2) has a key role to enable adaptation
to oxidative stress [5, 6] by transcriptionally controlling more than 2000, mainly cytoprotective
genes [7]. The induction of NRF2 genes requires a common NRF2-binding motif on the DNA,
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known as antioxidant response element (ARE) or electrophile response element (EpRE) [8, 9].
NRF2 also directly reduces the level of both ROS and RNS by promoting the expression of
their suppressors (i.e. catalase or nitric oxide synthase) [6]. Furthermore, NRF2 induces the
expression of other protective genes encoding phase I and II detoxification enzymes, transport
proteins, proteasome subunits, the regulators of various cell death mechanisms, antioxidant
proteins, growth factors, chaperones and other transcription factors [1, 10, 11].
It is well-known that mimicking oxidative stress by H2O2 or TBHP (tert-butyl-hydroperox-
ide) treatment results in activation of several signal transduction pathways of that stress
response mechanism; meanwhile the ongoing cell division cycle has to be blocked [12, 13]. At
physiological conditions the cell creates a precise duplication of its DNA content in S phase;
meanwhile segregation of sister chromatids occurs during mitosis (M phase) [14, 15]. S and M
phases are separated by gap phases, so called G1 (between M and S) and G2 (between M and
S) phases, respectively [14]. The maintenance of appropriate oscillation of these cell cycle
phases is controlled by a complex protein regulatory network [16]. The key protein molecules
of the cell cycle machinery are the cyclin dependent kinases (Cdks) [14]. The level of Cdks
remains relatively constant throughout the cell cycle, therefore their activity is controlled by
various posttranslational modifications (i.e. cyclin binding, cyclin activated kinase phosphory-
lation, regulatory phosphorylation and/or binding of Cdk inhibitor) [14, 17].
It is well-known that D-type cyclin has an essential role in controlling the start event of cell
cycle by binding Cdk4 or Cdk6 at physiological conditions [18, 19]. Besides that, many scien-
tific data have revealed that Cyclin D1 also plays an important role in G2 phase [20, 21]. How-
ever, Cyclin D1 seems to be sensitive to a variety of extracellular stimuli. It has shown that
activity of Cyclin D1 level is also modified by oxidative stimuli [22, 23]. It has been recently
clarified that high level of ROS induced by H2O2 treatment has a significant effect on the regu-
lation of D-type cyclin in human cells [12]. Cyclin D1 depletion is quickly detected after addi-
tion of oxidative stressor, meanwhile the cells become arrested in G2 phase. It is also
confirmed that Cyclin D1 is linked to the G2/M transition via the Chk1-Cdc2 DNA damage
checkpoint pathway in ROS-induced cell cycle block [12]. Interestingly, the down-regulation
of Cyclin D1 is highly controlled by one arm of the unfolded protein response mechanism
(UPR), called PERK pathway [12]. Namely, eiF2α, the direct target of PERK, seems to be
responsible for Cyclin D1 depletion in response to oxidative stress [12].
As it has been already shown, NRF2 is also a PERK substrate. The nuclear translocation of
NRF2 occurs in a PERK dependent manner with respect to endoplasmic reticulum (ER) stress
[24, 25]. In the absence of PERK the induction of NRF2 substrates (such as NRF2 target NAD
(P)H:quinone oxidoreductase 1 or NQO1 for short) is not detected [24]. Nrf2-/- cells are sensi-
tive to variety of ER stress inducing agents, while NRF2 overexpression enhances cell survival
suggesting that NRF2 signalling pathway is required for survival during ER stress-induced
UPR activation [25].
Since NRF2 is the key element of oxidative stress response mechanism and also a PERK
substrate, a question immediately arises, whether NRF2 has a role in controlling cell cycle
arrest via Cyclin D1 down-regulation upon oxidative stress. Here in this report we describe a
novel role of NRF2 in controlling cell cycle machinery by inhibiting Cyclin D1 throughout its
stoichiometric inhibitors at the initial stage of mild oxidative stress.
Materials and methods
Materials
Tert-Butyl hydroperoxide solution (Sigma-Aldrich, Luperox TBH70X, 458139) was purchased.
All other chemicals were of reagent grade.
Oxidative stress-induced NRF2-regulated cell cycle arrest
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Cell culture and maintenance
As a model system, human embryonic kidney (HEK293T, ATCC, CRL-3216) cell lines were
used, and maintained as described in detail previously [26]
Cell counting
After each treatment, the relative amount of viable cells was calculated by LUNA Automated
Cell Counter (Logos Biosystems). The cell counting was preceded by staining them with trypan
blue (0.4% stain, Logos Biosystems).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blot analysis
Cells were harvested and lysed and protein content of cell lysates was measured as described
previously [26] Whole cell lysates were separated by SDS-PAGE (in 10% or 15% SDS-polyacri-
lamide gel). SDS-PAGE and Western Blot analysis was done according to our previous study
[26]The following antibodies were applied: anti-NQO1 (Cell Signaling, A180), anti-CyclinD1
(Santa Cruz, A-12), anti-p21 (Santa Cruz, C-19), anti-p27 (Santa Cruz, C-19), anti-p15-INK4b
(proteintech, 12877-1-AP), anti-p16-INK4A (proteintech, 10883-1-AP), anti-PERK (Cell Sig-
naling, 3192S), anti-P-eIF2α (Cell Signaling, 9722S9), anti-P-eIF2α (Ser51) (Cell Signaling,
9721L), and anti-GAPDH (Santa Cruz, 6C5) and HRP conjugated secondary antibodies (San-
taCruz, sc-2020 and Cell Signaling, 7074S, 7076S).
Statistics
For densitometry analysis, Western blot data were acquired using ImageJ software, while the
statistical analysis was performed as described previously [26].
RNA interference
RNA interference experiments were performed as it was previously described [27].The siPERK
and siNRF2 oligonucleotides were purchased from Eurofins Genomics (the oligonucleotide
sequence: siPERK: 5’-GUGACGAAAUGGAACAAGA(dTdT)-3’; siNRF2: 5’-GGUUGAGA
CUACCAUGGUU (dTdT)-3’).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA content of cells was extracted using TRIzol RNA isolation reagent (Invitrogen)
[28]. Retrotranscription and real-time PCR was performed as we previously described [27]
PCR reaction and real-time detection was performed using PowerUp SYBR Green Master Mix
(Thermo Fisher Scientific, A25742) and QuantStudio 12K Flex System (Thermo Fisher Scien-
tific). The real-time PCR thermocycles were the followings: 95˚C 10 min (1x), 95˚C 15 s, 60˚C
1 min (40x), 95˚C 15 sec, 60˚C 1 min, 97˚C 15 s (1x). The primers were as follows: for PERK:
(forward) 5’-AAAGCAGTGGGATTTGGATG-3’ and (reverse) 5’-TCTTGGTCCCACTGGAA
GAG-3’, for NRF2: (forward) 5’-TCCAGTCAGAAACCAGTGGAT-3’ and (reverse) 5’-GA
ATGTCTGCGCCAAAAGCTG -3’, for GAPDH: (forward) 5’-TGCACCACCAACTGCTTAG
C-3’ and 5’-GGCATGGACTGTGGTCATGAG-3’.
Cell cycle analysis
HEK293T cells were incubated with 100 μM TBHP for 3 hours and with 30 μM TBHP for 6
hours (at the density of 6�105cells/ml). For cell cycle analysis, all floating and adhering cells
Oxidative stress-induced NRF2-regulated cell cycle arrest
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were trypsinized and then washed two times with cold PBS. Cells were fixed with 70% ethanol
at -24˚C overnight. Fixed cells were washed twice with PBS and then were treated with RNase
A (Thermo Fisher Scientific, EN0531) in the concentration of 10 μg/ml for 30 minutes at
37˚C. After incubation, cells were washed again with PBS and were re-suspended with 200 μl
PBS containing 40 μg/ml propidium iodide (Thermo Fisher Scientific, P3566) and analysed by
flow cytometry. Cell cycle analysis was performed on FACSCalibur (BD Bioscience) and the
percentage of cells in the different phases of cell cycle was calculated by FlowJo software.
Results
Cyclin D1 level is not decreasing at early stage of low level of oxidative stress
In order to test the effect of NRF2 in cell cycle regulation first we set up a protocol to induce
oxidative stress in human embryonic kidney cells (HEK293T) by using tert-butyl hydroperox-
ide (TBHP). TBHP is widely used to generate oxidative environment by reducing glutathione
level, peroxidising cellular lipids and altering cellular Ca2+ homeostasis [29, 30]. Our goal was
to introduce various levels of oxidative stress. By our definition mild oxidative stress does not
induce cell death mechanism; while excessive level of oxidative stress turns on the self-killing
mechanism. To verify whether TBHP treatment modifies cell cycle machinery, FACS analysis
was carried out by using propidium iodide staining (Fig 1). HEK293T cells were cultured in
the presence of 30 μM TBHP for 6 hours and 100 μM TBHP for 3 hours. A remarkable ten-
dency to cell cycle arrest was already observed after 3 hours assuming a relatively quick cellular
oxidative stress-response mechanism. The propidium iodide staining indicated that cell cycle
machinery already answered to a minimal oxidative treatment, but full cell cycle block cannot
be observed in this case. Therefore we can distinguish an early stage of treatment when the cell
response mechanism is just turned on in oxidative stress.
Although significant cell cycle arrest was not detected on population level upon short oxida-
tive stress, we intended to check whether cell cycle machinery has already started to induce its
response mechanism on molecular level. Since Pyo et al. has shown that Cyclin D1 protein
level got rapidly diminished during H2O2 treatment, Cyclin D1 was also detected by immuno-
blotting (Fig 2C and 2D). Excessive level of oxidative agent (300 μM TBHP for 1.5 hour) signif-
icantly decreased the amount of Cyclin D1 in the cells further confirming that the absence of
Cyclin D1 might have a key role to block cell cycle at G2 phase during oxidative stress. How-
ever this drastic drop of Cyclin D1 level was not detected when cells were treated with lower
concentration of TBHP (Fig 2C and 2D).
These results imply that diminish of Cyclin D1 is not required at early stage of cell cycle
response upon mild oxidative stress. Rather the control network requires some other mecha-
nism to block cell cycle progressing.
NRF2 is essential for cell cycle block at early stage of excessive oxidative stress
Next we explored the effect of both PERK and NRF2 during TBHP treatment. Although the
relative amount of viable cells was not affected at mild oxidative stress, 300 μM TBPH could
induce a significant increase in cell viability during either NRF2 or PERK silencing (Fig 2A).
Oxidative stress generated by addition of 100 μM TBHP for 1.5 hours was enough to enhance
the level of both NRF2 and PERK mRNA (Fig 2B). However 300 μM TBHP for 1.5 hours did
not increase neither NRF2 nor PERK mRNA levels (Fig 2B). Interestingly, a well-known NRF2
substrate, called NQO1 and also a PERK target, eiF2α-P, resulted in a drastic elevation on pro-
tein level upon either 100 or 300 μM TBHP treatments supposing that both NRF2 and PERK
got activated both at mild and excessive levels of short oxidative stress (Fig 2C and 2D).
Oxidative stress-induced NRF2-regulated cell cycle arrest
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Western blot experiments were also performed when TBHP treatment was preceded by
silencing of PERK with siRNA (Fig 2B). In this case Cyclin D1 level did not change after 1.5
hours long treatment with 100 μM TBHP, however the level of Cyclin D1 also remained high
after addition of 300 μM TBHP. Our data confirm that PERK is essential to promote the
induction of Cyclin D1-dependent cell cycle arrest at high level of oxidative stress, although we
could not verify whether PERK has a role or not in controlling this process at short treatment
with 100 μM TBHP. Interestingly, similar results were observed when NRF2 was silenced by
using siRNA, namely Cyclin D1 level remained high upon excessive level of oxidative stress
(Fig 2C and 2D). Although eiF2α-P was significantly increased in these cells, in the absence of
NRF2 Cyclin D1 level did not decrease at all. Our data suppose that eiF2α-P alone is not suffi-
cient to promote Cyclin D1 degradation rather NRF2 has some effect on it upon high level of
oxidative stress. However Cyclin D1 expression seems to be not affected when NRF2 was
silenced by using siRNA at low level of TBHP treatment.
Fig 1. Cell cycle block gets induced even at early stage of low level of oxidative stress. Flow cytometry cell cycle analysis of TBHP-treated HEK293T cells. (A) Cells
were treated with 30 μM TBHP for 6 hours and 100 μM TBHP for 3 hours. After fixation, cell cycle analysis was performed with propidium iodide staining. Curve fitting
and calculating the different phases of cell cycle were measured by FlowJo Software. (B) Summary table of the cell cycle distribution in different samples. (C) Overlay
histogram of the cell cycle analysis was also made by FlowJo Software.
https://doi.org/10.1371/journal.pone.0207949.g001
Oxidative stress-induced NRF2-regulated cell cycle arrest
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Our data suggest that beside PERK-induced eiF2α-P, another PERK substrate, NRF2 also
has an essential role in down-regulating Cyclin D1 and therefore it promotes the initiation of
cell cycle arrest at excessive level of oxidative stress.
Silencing of PERK results in depletion of Cyclin D1 inhibitors during low
level of oxidative stress
Our results confirm that both PERK and its target NRF2 are essential at treatment with exces-
sive level of oxidative agent to down-regulate Cyclin D1. However our data also indicate that
Cyclin D1 level is not affected at early stage of mild oxidative stress. In our lab it got emerged
that this key cyclin of cell cycle machinery is regulated with a much quicker process (e.g. by
posttranslational modification), as well. It is well-known that Cyclin D1 is controlled by
Fig 2. Cyclin D1 degradation is not observed at early stage of low level of oxidative stress. Concentration dependency of oxidative stress treatment was followed
with/without a background of PERK or NRF2 silencing. HEK293T cells were cultured with 100 or 300 μM TBHP for 1.5 hours, while NRF2 or PERK gene expression
was depleted by NRF2 or PERK siRNA. (A) The relative amount of viable HEK293T cells. (B) The efficiency of NRF2 (upper panel) and PERK (lower panel) silencing
was checked on mRNA level. The mRNA level was followed by real-time PCR. GAPDH was used as a housekeeping gene. The intensity of NRF2 is normalised for
GAPDH. (C) During oxidative stress the markers of NRF2 (NQO1), PERK (PERK-T, eiF2α -P) and Cyclin D1 were followed by immunoblotting. GAPDH was used as a
loading control. (D) Densitometry data represent the intensity of NQO1, PERK-T and Cyclin D1 normalised for GAPDH and eiF2α-P normalized for total level of
eiF2α. For each of the experiments, three independent measurements were carried out. Error bars represent standard deviation; asterisks indicate statistically significant
difference from the control: ⁎ p< 0.05; ⁎⁎ p< 0.01.
https://doi.org/10.1371/journal.pone.0207949.g002
Oxidative stress-induced NRF2-regulated cell cycle arrest
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various inhibitors at the different phases of cell cycle progress. While stoichiometric inhibitors
p15 and p16 have essential roles in G1 phase; both p21 and p27 inhibit Cyclin D1 in G2 phase
[31–33]. Therefore we assume that Cyclin D1 activity is controlled by some of these inhibitors
at early stage of oxidative stress.
In order to explore further the oxidative stress response mechanism first we studied the
effect of mild oxidative stress (100 μM TBHP) on HEK293T cells in time-dependent manner
combined with/without silencing of PERK with siRNA. To confirm that PERK silencing was
effective, the expression level of its mRNA was followed by real-time PCR (Fig 3A). Cells grow-
ing 0.5, 1 and 2 hours in 100 μM TBHP have shown a significant eiF2α phosphorylation sug-
gesting that PERK pathway got activated; however eiF2α became dephosphorylated upon 3
Fig 3. Silencing of PERK down-regulates Cyclin D1 inhibitors at early stage of oxidative stress. Time dependency of oxidative stress treatment was followed with/
without a background of PERK silencing. HEK293T cells were cultured with TBHP for 0.5-1-2-3 hours, while PERK gene expression was depleted by PERK siRNA. (A)
Testing the effectiveness of RNA silencing. PERK mRNA level was followed by real-time PCR in cell culture containing PERK siRNA. GAPDH was used as a
housekeeping gene. The intensity of PERK is normalised for GAPDH. (B) During oxidative stress the markers of NRF2 (NQO1), PERK (PERK-T, eiF2α -P), Cyclin D1
and its inhibitors (p15, p16, p21, p27) were followed by immunoblotting. GAPDH was used as a loading control. (C) Densitometry data represent the intensity of
NQO1, PERK-T, Cyclin D1, p15, p16, p21 and p27 normalised for GAPDH and eiF2α-P normalized for total level of eiF2α. For each of the experiments, three
independent measurements were carried out. Error bars represent standard deviation; asterisks indicate statistically significant difference from the control: ⁎ p< 0.05;
⁎⁎ p< 0.01.
https://doi.org/10.1371/journal.pone.0207949.g003
Oxidative stress-induced NRF2-regulated cell cycle arrest
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hours long oxidative stress. No eiF2α phosphorylation was observed when PERK was silenced
with siRNA in HEK293T cells.
Next, we followed the Cyclin D1 inhibitors (i.e. p15, p16, p21 and p27) by immunoblotting.
As shown in Fig 3B and 3C, the level of p15, p21 and 27 resulted in a time-dependent increase,
suggesting their essential role with respect to oxidative stress. p15, p21 and p27 performed a
fast and significant activation peak already after 1 hour TBHP treatment, meanwhile Cyclin
D1 level did not change at all. These results assume that Cyclin D1 might be regulated by their
stoichiometric inhibitors at mild level of TBHP and the induction of cell cycle block might be
achieved by this posttranslational modification at early stage of oxidative stress. In PERK
silenced cells no p15, p21 and p27 activity was detected further confirming that PERK has a
crucial role in regulating Cyclin D1 via its inhibitors upon oxidative stress. Interestingly, p16
level did not show any increase during TBHP treatment (Fig 3B and 3C). Besides that, PERK
silencing did not have any effect on p16 protein level, suggesting that p16 was not part of the
oxidative stress response mechanism.
Collectively, these results suggest that PERK has an essential role in controlling cell cycle pro-
gression via inducing Cyclin D1 inhibitors at initial stage of permanent mild oxidative stress.
NRF2 is essential to up-regulate Cyclin D1 inhibitors upon low level of
oxidative stress
Next, our goal was to verify the role of NRF2 in cell cycle progression upon oxidative stress. The
longer cells were treated with 100 μM TBHP, the more NRF2 mRNA was present in HEK293T
cells (Fig 4A). Decrease in NRF2 mRNA level was not observed when TBHP treatment was
combined with PERK siRNA (Fig 2B); however its well-known target, NQO1 did not show a
Fig 4. Silencing of NRF2 down-regulates Cyclin D1 inhibitors at early stage of oxidative stress. Time dependency
of oxidative stress treatment was followed with/without a background of NRF2 silencing. HEK293T cells were cultured
with TBHP for 0.5-1-2-3 hours, while NRF2 gene expression was depleted by NRF2 siRNA. (A) Testing the
effectiveness of RNA silencing. NRF2 mRNA level was followed by real-time PCR in cell culture containing NRF2
siRNA. GAPDH was used as a housekeeping gene. The intensity of NRF2 is normalised for GAPDH. (B) During
oxidative stress the markers of NRF2 (NQO1), PERK (PERK-T, eiF2α -P), Cyclin D1 and its inhibitors (p15, p16, p21,
p27) were followed by immunoblotting. GAPDH was used as a loading control. (C) Densitometry data represent the
intensity of NQO1, PERK-T, Cyclin D1, p15, p16, p21 and p27 normalised for GAPDH and eiF2α-P normalized for
total level of eiF2α. For each of the experiments, three independent measurements were carried out. Error bars
represent standard deviation; asterisks indicate statistically significant difference from the control: ⁎ p< 0.05;
⁎⁎ p< 0.01.
https://doi.org/10.1371/journal.pone.0207949.g004
Oxidative stress-induced NRF2-regulated cell cycle arrest
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significant increase on protein level even after 3 hours TBHP treatment (Fig 3B and 3C). These
results suggest that NRF2 cannot become catalytically active in the absence of PERK assuming
that NRF2 might require some PERK-dependent modification upon oxidative stress.
Since NRF2 activity seems to be constantly low in the absence of PERK, a question immedi-
ately arises, namely, what can be the effect of PERK on NRF2. Various online available data-
bases (such as MINT, IntAct) indicate an observable interaction between PERK and NRF2
suggesting a PERK-dependent regulation on NRF2 [34]. Cullinan et al. have also recently iden-
tified NRF2 as a PERK substrate [24, 25]. They claimed that ER stress-dependent PERK induc-
tion is essential both for dissociation of cytoplasmic NRF2/KEAP1 complex and subsequent
NRF2 nuclear import [24]. Cullinan et al. have suggested that PERK might control NRF2 activ-
ity by phosphorylation [24], and here we also assume that NRF2 gets enhanced in a PERK-
dependent manner (Fig 3B and 3C).
Besides the down-regulation of Cyclin D1 inhibitors (i.e. p15, p21, p27), NRF2 activity was
also suppressed in the absence of PERK in response to oxidative stress. However, it was not
clear whether NRF2 is able to regulate the stoichiometric inhibitors of Cyclin D1 to induce cell
cycle arrest upon oxidative stress. Recently, by a global mapping of binding sites for NRF2
Malhotra et al. have shown that NRF2 can bind to the promoter of p15, p21 and p27 [35].
They also claimed that NRF2 might have a positive effect on these stoichiometric inhibitors of
Cyclin D1, although further studies were also suggested. Therefore we investigated the direct
role of NRF2 on Cyclin D1 inhibitors (p15, p16, p21 and p27) upon oxidative stress.
In order to further evaluate the importance of NRF2 in cell cycle progression, we analysed
the time-dependency of addition of 100 μM TBHP in HEK293T cells pre-treated with NRF2
siRNA (Fig 4). To confirm that the silencing was successful NRF2 mRNA level was tested by
real-time PCR (Fig 4A). In addition, by immunoblotting the absence of NQO1 protein level in
TBHP treatment combined with NRF2 siRNA was also verified that NRF2 did not have any
activity in this case (Fig 4B and 4C). As shown in Fig 4B and 4C, eiF2α phosphorylation was
observed in a time-dependent manner during TBHP treatment suggesting that NRF2 does not
have any feedback effect on neither PERK nor its target.
To verify the relationship between NRF2 and Cyclin D1 inhibitors upon prolonged but
mild oxidative stress, the expression level of Cyclin D1, p15, p16, p21 and p27 was analysed by
Western blot in HEK293T cells pre-treated with/without siNRF2 (Fig 4B and 4C). Both Cyclin
D1 and p16 level were constant during TBHP treatment even in the absence of NRF2 suggest-
ing that NRF2 did not affect these proteins at early stage of mild oxidative stress. While the
protein level of p15, p21 and p27 has significantly increased upon prolonged oxidative stress in
a time-dependent manner, we observed the complete diminish of these stoichiometric inhibi-
tors in NRF2-silenced cells (Fig 4B and 4C).
These results imply that NRF2 is required for initiation of early stage of cell cycle block to
induce Cyclin D1 inhibitors upon mild oxidative stress.
Induction of Cyclin D1 inhibitors is always observed at early stage of
oxidative stress
Finally, we attempted to determine whether the activation profile of Cyclin D1 inhibitors
shows any differences at early stage of mild and excessive oxidative stress levels. Therefore
HEK293T cells were treated with 100 or 300 μM TBHP and expression level of Cyclin D1 and
its inhibitors (p15, p16, p21 and p27) were followed by immunoblotting.
As shown in Fig 5A and 5B Cyclin D1 level got significantly decreased when 300 μM TBHP
was added to HEK293T cells suggesting that cell cycle progression is definitively regulated
through Cyclin D1 level at excessive level of oxidative stress. In contrast, p15, p21 and p27
Oxidative stress-induced NRF2-regulated cell cycle arrest
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levels resulted in a drastic increase at both mild and excessive oxidative stress levels, meanwhile
p16 level was not affected at all. These results further confirm that although p16 is a well-
known inhibitor of Cyclin D1, it does not have any role in controlling the early stage of cellular
stress-response mechanism with respect to oxidative stress.
Our results suggest that the posttranslational regulation of Cyclin D1 by its inhibitors
always occurs at early stage of oxidative stress cell supposing that besides controlling Cyclin
D1 level its down-regulation is also essential.
Discussion
Oxidative stress generated by internal metabolism or environmental toxicant exposure affects
many cellular functions, including various signalling pathways. The transcription factor NRF2
is a key element of the main signalling pathway responsible to cell defence against oxidative
stress. NRF2 is an emerging regulator of cellular resistance to oxidative attacks by controlling
the transcription of hundreds of mainly cytoprotective genes. The role of NRF2 in maintaining
the cellular redox balance is deeply explored, although its effect in cell cycle progression upon
oxidative stress is not well-studied yet. Recently Pyo et al. have revealed that PERK pathway,
one of the three main branches of unfolded protein response (UPR) is important to block cells
in G2 phase with respect to oxidative stress [12]. Since it has been also shown that NRF2 activ-
ity is regulated by PERK [24], in this report we explored whether this cell cycle regulation is
NRF2-dependent or not with response to oxidative stress.
Using HEK293T cell line we successfully set up a protocol when the initiation stage of cell
cycle arrest was detected during oxidative stress. With TBHP we could find proper treatment
when cells seemed to be already committed to cell cycle arrest, but has not blocked yet in G2
phase (Fig 1). Pyo et al have already shown that Cyclin D1 quickly got decreased at oxidative
stress resulting in a cell cycle block in G2 phase [12]. We observed similar depletion of Cyclin
Fig 5. Short treatment with high level of oxidative stress induces Cyclin D1 inhibitors. (A) HEK293T cells were
treated with 100 or 300 μM TBHP for 1.5 hour and the markers of NRF2 (NQO1), PERK (PERK-T, eiF2α -P), Cyclin
D1 and its inhibitors (p15, p16, p21, p27) were followed by immunoblotting. GAPDH was used as a loading control.
(B) Densitometry data represent the intensity of NQO1, PERK-T, Cyclin D1, p15, p16, p21 and p27 normalised for
GAPDH and eiF2α-P normalized for total level of eiF2α. For each of the experiments, three independent
measurements were carried out. Error bars represent standard deviation; asterisks indicate statistically significant
difference from the control: ⁎ p< 0.05; ⁎⁎ p< 0.01. (C) The hypothetic control network of cell cycle regulatory system
with respect to oxidative stress.
https://doi.org/10.1371/journal.pone.0207949.g005
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D1 when the cells were treated with high level of TBHP; however no Cyclin D1 degradation
was detected upon mild level of oxidative stress (Fig 2). This observation was further con-
firmed by the fact that Cyclin D1 level was even higher after 3 hours long treatment with
100 μM TBHP (Figs 3 and 4). This suggests that Cyclin D1 might get accumulate at the early
stage of mild oxidative stress; therefore the control system requires a completely different
mechanism to induce cell cycle block. Interestingly, the level of stoichiometric inhibitors of
Cyclin D1 (i.e. p15, p21 and p27) has quickly shown a significant increase (Figs 2–4). This is
the first study we have shown that cell cycle arrest got achieved via posttranslational modifica-
tion of Cyclin D1 rather protein degradation upon mild oxidative stress.
To figure out whether in this system the above mentioned observation is connected to
NRF2, the effect of both PERK and NRF2 was checked by silencing either PERK or NRF2 with
its corresponding siRNA. Our results revealed that the absence of either of these proteins has a
dramatic effect on oxidative stress response mechanism suggesting the abolition of cell cycle
block. Namely, stoichiometric inhibitors of Cyclin D1 (i.e. p15, p21 and p27) remained inac-
tive even after 3 hours long treatment with low level of TBHP (Figs 2–4). Here we verify that
both PERK and NRF2 are essential for proper cell cycle progression upon oxidative stress.
Recently it has shown that key substrate of PERK, called eiF2α-P is crucial to promote
Cyclin D1 degradation and therefore arrests cell cycle at G2 phase with respect to oxidative
stress [12]. Cyclin D1 depletion was clearly observed by generating a high level of oxidative
stress with H2O2 addition [12]; however they did not check the effect of a much weaker oxida-
tive exposure. In this study we reveal that PERK pathway by inducing its other downstream
target NRF2 controls cell cycle progression both at permanent mild and short but excessive
level of oxidative stress. Although both the initiation of cell cycle arrest and an increase of
eiF2α-P level were observed when cells were treated with 100 μM TBHP, no Cyclin D1 degra-
dation was detected (Figs 1 and 2). Cyclin D1 degradation becomes significant even at early
stage of excessive level of oxidative stress (i.e. using 300 μM TBHP), however the activation of
p15, p21 and p27 was also observed (Fig 5A and 5B) suggesting that the stoichiometric inhibi-
tors always play an essential role in oxidative exposure.
Here we assume that PERK controls cell cycle progression via both substrates (i.e. NRF2,
eiF2α-P). NRF2-dependent and eiF2α-P-dependent pathways are not independent from each
other rather they are complementary. At early stage of mild oxidative stress the control system
quickly enhances the initiation of cell cycle arrest via enhancing Cyclin D1 inhibitors in an
NRF2-dependent manner. With silencing of NRF2 upon oxidative stress here we show that
this cell cycle arrest is eiF2α-P-independent (Fig 4). However, excessive level of oxidative stress
turns on eiF2α-P-dependent Cyclin D1 degradation. Since Cyclin D1 inhibitors got activated
even at high level of oxidative stress (Fig 5A and 5B), we suggest that NRF2-dependent stress
response mechanism always plays an essential role in early stage of oxidative stress.
In this study we suggest that Cyclin D1 degradation takes time, therefore the stress response
mechanism requires a much faster answer via posttranslational modification. Namely, the con-
trol network up-regulates the stoichiometric inhibitors of Cyclin D1 to guarantee a rapid com-
mitment to cell cycle arrest if the exposure of oxidative agent is intolerable. Here we also
suppose that the inhibition of Cyclin D1 is followed later by the down-regulation of Cyclin D1
upon excessive level of oxidative stress (Fig 5C). Meanwhile Cyclin D degradation is not
observed at mild oxidative stress even after 3 hours. Since the conditions are not so drastic, the
system wants to be capable to re-activate Cyclin D1 and therefore it re-induces cell cycle pro-
gression as soon as the oxidative exposure gets diminished and the cells can successfully
recover. Although NRF2 is a PERK substrate, here we show that mRNA level of PERK did not
change upon oxidative stress in the absence of NRF2 (Fig 4). Besides, an intensive eiF2α phos-
phorylation was also observed with NRF2 siRNA suggesting that NRF2 does not have any
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effect on PERK activity either. Interestingly, Sandelin et al. have revealed that NRF2, as a tran-
scription factor, can bind to the promoter region of PERK gene [34], supposing an NRF2-dri-
ven feedback effect on PERK. This result seems to be contradictory to our experimental data;
however, we cannot rule out that this feedback effect of NRF2 on PERK is not manifested
upon oxidative stress. This assumption needs further analysis in the future.
Besides p15, p16 is the main stoichiometric inhibitor of Cyclin D1 and plays a crucial role
in controlling G1/S transition [36, 37]. Furthermore it was also confirmed that p15 is the medi-
ator of TGF-β-induced cell cycle arrest and it might inhibit the growth of various tumour cells
[38]. Here we show that, contrary to p15, p16 is not affected at all during early stage of either
mild or excessive level of oxidative stress (Fig 2). In addition p16 seemed to be also constant
when NRF2 was silenced by siRNA upon oxidative exposure (Fig 4B and 4C). Our results sug-
gest that p16 is not taking part in cell cycle control during oxidative stress. It might be also con-
ceivable that p16 has role in blocking cell cycle progression after a longer oxidative exposure.
To explore the role of NRF2 in controlling cell cycle progression upon oxidative stress is a
pivotal point of our study, since the most commonly occurring complex diseases of the society
(i.e. neurodegenerative diseases, metabolic diseases and carcinogenesis) generate oxidative
stress in the human cellular system. E.g. neurons are blocked in G0 phase at physiological con-
ditions, but cells quickly enter mitosis followed by apoptosis during Alzheimer’s disease [39,
40]. NRF2 level is low in the nucleus during Alzheimer’s disease, meanwhile strong oxidative
stress is observed. We claim that our experimental condition, namely, NRF2 silencing com-
bined with oxidative exposure, nicely mimics the Alzheimer’s disease on cellular level. Our
data suggest that absence of Cyclin D1 inhibitors (i.e. p15, p21 and p27) might have an essen-
tial role in disturbing the cell cycle machinery during degradation of neurons. Therefore in
this report we further suppose the cytoprotective effect of NRF2.
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Supervision: Gábor Bánhegyi, Orsolya Kapuy.
Validation: Margita Márton, Gábor Bánhegyi, Orsolya Kapuy.
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